{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:57:10Z","timestamp":1760954230429},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10863-021-09900-9","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T21:03:31Z","timestamp":1620680611000},"page":"441-448","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Hypoxia-induced HIF1\u03b1 dependent COX2 promotes ovarian cancer progress"],"prefix":"10.1007","volume":"53","author":[{"given":"Yumei","family":"Ding","sequence":"first","affiliation":[]},{"given":"Shichao","family":"Zhuang","sequence":"additional","affiliation":[]},{"given":"Yujiao","family":"Li","sequence":"additional","affiliation":[]},{"given":"Xiaohui","family":"Yu","sequence":"additional","affiliation":[]},{"given":"Ming","family":"Lu","sequence":"additional","affiliation":[]},{"given":"Ning","family":"Ding","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,5,10]]},"reference":[{"key":"9900_CR1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0002-9440(10)63661-9","volume":"163","author":"R Agarwal","year":"2003","unstructured":"Agarwal R (2003) The function of COX-2 in human ovarian carcinoma. Am J Pathol 163:368; author reply 368\u2013369\u2013369","journal-title":"Am J Pathol"},{"key":"9900_CR2","first-page":"1661","volume":"7","author":"P Birner","year":"2001","unstructured":"Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G (2001) Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res: An Off J Am Assoc Cancer Res 7:1661\u20131668","journal-title":"Clin Cancer Res: An Off J Am Assoc Cancer Res"},{"key":"9900_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/biomedicines5020021","volume":"5","author":"L D\u2019Ignazio","year":"2017","unstructured":"D\u2019Ignazio L, Batie M, Rocha S (2017) Hypoxia and inflammation in cancer, focus on HIF and NF-kappaB. Biomedicines 5:21","journal-title":"Biomedicines"},{"key":"9900_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1631\/jzus.B1900445","volume":"21","author":"L Deng","year":"2020","unstructured":"Deng L, Feng DQ, Ling B (2020) Cyclooxygenase-2 promotes ovarian cancer cell migration and cisplatin resistance via regulating epithelial mesenchymal transition. J Zhejiang Univ Sci B 21:315\u2013326","journal-title":"J Zhejiang Univ Sci B"},{"key":"9900_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11523-018-0555-4","volume":"13","author":"JW DiGiacomo","year":"2018","unstructured":"DiGiacomo JW, Gilkes DM (2018) Tumor hypoxia as an enhancer of inflammation-mediated metastasis: emerging therapeutic strategies. Target Oncol 13:157\u2013173","journal-title":"Target Oncol"},{"key":"9900_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-3-030-12734-3_10","volume":"1136","author":"JW DiGiacomo","year":"2019","unstructured":"DiGiacomo JW, Gilkes DM (2019) Therapeutic strategies to block the hypoxic response. Adv Exp Med Biol 1136:141\u2013157","journal-title":"Adv Exp Med Biol"},{"key":"9900_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10067-018-4395-5","volume":"38","author":"L El Khoury","year":"2019","unstructured":"El Khoury L, Furie R (2019) Inflammatory arthritis: a unique presentation of human anaplasmosis. Clin Rheumatol 38:257\u2013259","journal-title":"Clin Rheumatol"},{"key":"9900_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/cge.13566","volume":"97","author":"N Flaum","year":"2020","unstructured":"Flaum N, Crosbie EJ, Edmondson RJ, Smith MJ, Evans DG (2020) Epithelial ovarian cancer risk: a review of the current genetic landscape. Clin Genet 97:54\u201363","journal-title":"Clin Genet"},{"key":"9900_CR9","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1073\/pnas.1803999116","volume":"116","author":"A Gartung","year":"2019","unstructured":"Gartung A, Yang J, Sukhatme VP, Bielenberg DR, Fernandes D, Chang J, Schmidt BA, Hwang SH, Zurakowski D, Huang S, Kieran MW, Hammock BD, Panigrahy D (2019) Suppression of chemotherapy-induced cytokine\/lipid mediator surge and ovarian cancer by a dual COX-2\/sEH inhibitor. Proc Natl Acad Sci U S A 116:1698\u20131703","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9900_CR10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1470-2045(03)01220-8","volume":"4","author":"G Gasparini","year":"2003","unstructured":"Gasparini G, Longo R, Sarmiento R, Morabito A (2003) Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? Lancet Oncol 4:605\u2013615","journal-title":"Lancet Oncol"},{"key":"9900_CR11","doi-asserted-by":"crossref","unstructured":"Harris\u00a0RE (2015) Ibuprofen in the prevention and therapy of cancer. Ibuprofen: Discovery, Development and Therapeutics, John Wiley & Sons, pp 518\u2013546","DOI":"10.1002\/9781118743614.ch13"},{"key":"9900_CR12","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/ijc.27448","volume":"131","author":"A Horiuchi","year":"2012","unstructured":"Horiuchi A, Hayashi T, Kikuchi N, Hayashi A, Fuseya C, Shiozawa T, Konishi I (2012) Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1\u03b1 to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene. Int J Cancer 131:1755\u20131767","journal-title":"Int J Cancer"},{"key":"9900_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","volume":"38","author":"P Icard","year":"2018","unstructured":"Icard P, Shulman S, Farhat D, Steyaert JM, Alifano M, Lincet H (2018) How the Warburg effect supports aggressiveness and drug resistance of cancer cells? Drug Resist Updates: Rev Commentaries Antimicrob Anticancer Chemother 38:1\u201311","journal-title":"Drug Resist Updates: Rev Commentaries Antimicrob Anticancer Chemother"},{"key":"9900_CR14","doi-asserted-by":"publisher","first-page":"6683","DOI":"10.1158\/0008-5472.CAN-06-0425","volume":"66","author":"A Kaidi","year":"2006","unstructured":"Kaidi A, Qualtrough D, Williams AC, Paraskeva C (2006) Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res 66:6683\u20136691","journal-title":"Cancer Res"},{"key":"9900_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000485624","volume":"94","author":"H Kemilainen","year":"2018","unstructured":"Kemilainen H, Huhtinen K, Auranen A, Carpen O, Strauss L, Poutanen M (2018) The expression of HSD17B12 is associated with COX-2 expression and is increased in high-grade epithelial ovarian cancer. Oncology 94:233\u2013242","journal-title":"Oncology"},{"key":"9900_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","volume":"26","author":"C La Vecchia","year":"2017","unstructured":"La Vecchia C (2017) Ovarian cancer: epidemiology and risk factors. Eur J Cancer Prev: The Off J Eur Cancer Prev Organ (ECP) 26:55\u201362","journal-title":"Eur J Cancer Prev: The Off J Eur Cancer Prev Organ (ECP)"},{"key":"9900_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/978-3-030-34461-0_34","volume":"1232","author":"HJ Lee","year":"2020","unstructured":"Lee HJ, Han HJ (2020) Role of microtubule-associated factors in HIF1alpha nuclear translocation. Adv Exp Med Biol 1232:271\u2013276","journal-title":"Adv Exp Med Biol"},{"key":"9900_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-3-030-34461-0_18","volume":"1232","author":"G Multhoff","year":"2020","unstructured":"Multhoff G, Vaupel P (2020) Hypoxia compromises anti-cancer immune responses. Adv Exp Med Biol 1232:131\u2013143","journal-title":"Adv Exp Med Biol"},{"key":"9900_CR19","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/annonc\/mdf312","volume":"13","author":"ML Nasi","year":"2002","unstructured":"Nasi ML, Castiglione M (2002) Cyclooxygenase-2 (COX-2) a new prognostic and predictive factor for ovarian cancer? Are all the criteria fulfilled? Ann Oncol: Off J Eur Soc Med Oncol 13:1169\u20131171","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol"},{"key":"9900_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/cancers12010213","volume":"12","author":"JM Pantshwa","year":"2020","unstructured":"Pantshwa JM, Kondiah PPD, Choonara YE, Marimuthu T, Pillay V (2020) Nanodrug delivery systems for the treatment of ovarian cancer. Cancers 12:213","journal-title":"Cancers"},{"key":"9900_CR21","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1002\/cncr.11847","volume":"98","author":"IH Roland","year":"2003","unstructured":"Roland IH, Yang WL, Yang DH, Daly MB, Ozols RF, Hamilton TC, Lynch HT, Godwin AK, Xu XX (2003) Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies. Cancer 98:2607\u20132623","journal-title":"Cancer"},{"key":"9900_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721\u2013732","journal-title":"Nat Rev Cancer"},{"key":"9900_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20100136","volume":"32","author":"G Sethi","year":"2012","unstructured":"Sethi G, Shanmugam MK, Ramachandran L, Kumar AP, Tergaonkar V (2012) Multifaceted link between cancer and inflammation. Biosci Rep 32:1\u201315","journal-title":"Biosci Rep"},{"key":"9900_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-3-030-34461-0_21","volume":"1232","author":"P Vaupel","year":"2020","unstructured":"Vaupel P, Multhoff G (2020) Fatal alliance of hypoxia-\/HIF-1alpha-driven microenvironmental traits promoting cancer progression. Adv Exp Med Biol 1232:169\u2013176","journal-title":"Adv Exp Med Biol"},{"key":"9900_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cbi.2018.06.020","volume":"292","author":"YP Wang","year":"2018","unstructured":"Wang YP, Wang QY, Li CH, Li XW (2018) COX-2 inhibition by celecoxib in epithelial ovarian cancer attenuates E-cadherin suppression through reduced snail nuclear translocation. Chem Biol Interact 292:24\u201329","journal-title":"Chem Biol Interact"},{"key":"9900_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/cancers10080261","volume":"10","author":"JRH Wendel","year":"2018","unstructured":"Wendel JRH, Wang X, Hawkins SM (2018) The endometriotic tumor microenvironment in ovarian cancer. Cancers 10:261","journal-title":"Cancers"},{"key":"9900_CR27","doi-asserted-by":"crossref","unstructured":"Yeh YH, Hsiao HF, Yeh YC, Chen TW, Li TK (2018) Inflammatory interferon activates HIF-1a-mediated epithelial-to-mesenchymal transition via PI3K\/AKT\/mTOR pathway. J Exp Clin Cancer Res 37:70","DOI":"10.1186\/s13046-018-0730-6"},{"key":"9900_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-3-030-12734-3_6","volume":"1136","author":"T Zhang","year":"2019","unstructured":"Zhang T, Suo C, Zheng C, Zhang H (2019) Hypoxia and metabolism in metastasis. Adv Exp Med Biol 1136:87\u201395","journal-title":"Adv Exp Med Biol"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-021-09900-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-021-09900-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-021-09900-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T23:07:56Z","timestamp":1672096076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10863-021-09900-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["9900"],"URL":"https:\/\/doi.org\/10.1007\/s10863-021-09900-9","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,10]]},"assertion":[{"value":"7 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were approved by the Ethical Commitment of ZIBO Central Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}